1) primary progressive multiple sclerosis
原发进展型多发性硬化
1.
Objective The clinical features of 8 patients with primary progressive multiple sclerosis (PPMS) in our department were investigated.
目的 分析我院 8例原发进展型多发性硬化 (PPMS)患者的临床特征。
2) Progressive multiple sclerosis
进展型多发性硬化
1.
Efficacy and safety of hematopoietic stem cell mobilization by granulocyte colony-stimulation factor in patients with progressive multiple sclerosis;
粒系集落刺激因子对进展型多发性硬化患者造血干细胞的动员效果及安全性
3) Relapsing-remitting MS
复发-缓解型多发性硬化
4) relapsing-remitting form of multiple sclerosis
缓解-复发型多发性硬化
1.
Study on the changes of IL-12p40、IFN-γ in relapsing-remitting form of multiple sclerosis and bacterial meningitis;
缓解-复发型多发性硬化和化脓性脑膜炎患者IL-12p40、IFN-γ水平的研究
5) multiple sclerosis
多发性硬化
1.
Effect of glucocorticoid on expression of CD40 and CD40 ligand of peripheral blood lymphocyte in patients with multiple sclerosis;
糖皮质激素对多发性硬化患者外周血淋巴细胞CD40和CD40L表达的影响
2.
Texture analysis on normal appearing white matter in patients with multiple sclerosis based on fractal theory;
基于分形维理论的多发性硬化患者脑白质的纹理特征分析
3.
Clinical features of late-onset multiple sclerosis:analysis of 60 cases;
60例晚发型多发性硬化患者的临床分析
6) MS
[英][,em 'es] [美]['ɛm 'ɛs]
多发性硬化
1.
Analysis of 100 inpatients with Multiple Sclerosis (MS);
100例多发性硬化的发作性症状临床分析
2.
The effect of early psychological rehabilitation on MS patients with depression;
早期心理康复对多发性硬化患者抑郁症状的效果观察
3.
Analysis of myelin oligodendrocyte glycoprotein(MOG) antibody in patients with multiple sclerosis(MS) and its significance;
多发性硬化患者抗髓鞘少突胶质细胞糖蛋白抗体的检测及其意义
补充资料：多发性硬化症
多发性硬化症
multiple sclerosis
是以中枢神经系统的多发病灶为特点的一种中枢神经系统脱髓鞘疾病。病情有缓解和复发的倾向，病因不明，可能与病毒感染和自身免疫有关。多见于青壮年，临床症状复杂多变，呈发作与缓解相交替出现，可有精神症状、言语障碍、颅神经(Ⅱ、Ⅲ、Ⅳ等）功能障碍、感觉障碍(如针刺感、麻木感）、少数病例可引起尿频、尿急等膀胱刺激症状。目前还没有针对性治疗药物，可用肾上腺皮质激素和免疫抑制剂。注意避免损伤、过劳、情绪激动、感染等诱发因素，并注意适当营养。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条